Vorinostat Active Not Recruiting Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01617226Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS